Discontinuation report XARELTO
| Report ID | 68808 |
| Drug Identification Number | 02441535 |
| Brand name | XARELTO |
| Common or Proper name | rivaroxaban |
| Company Name | BAYER INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RIVAROXABAN RIVAROXABAN |
| Strength(s) | 15MG 20MG |
| Dosage form(s) | TABLET KIT |
| Route of administration | ORAL |
| Packaging size | 49 |
| ATC code | B01AF |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-12-01 |
| Actual discontinuation date | 2018-12-01 |
| Remaining supply date | 2018-12-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2018-12-05 | French | Compare |
| v2 | 2018-12-05 | English | Compare |
| v1 | 2018-12-05 | English | Compare |
Showing 1 to 3 of 3